CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 99 filers reported holding CUE BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is 9.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $97,971 | +444.3% | 33,900 | +2265.7% | 0.00% | – |
| Q1 2021 | $18,000 | -72.7% | 1,433 | -72.3% | 0.00% | – |
| Q4 2020 | $66,000 | +120.0% | 5,173 | +171.1% | 0.00% | – |
| Q3 2020 | $30,000 | -52.4% | 1,908 | -31.8% | 0.00% | – |
| Q2 2020 | $63,000 | +800.0% | 2,798 | +446.5% | 0.00% | – |
| Q1 2020 | $7,000 | -85.7% | 512 | -83.4% | 0.00% | – |
| Q4 2019 | $49,000 | +157.9% | 3,078 | +31.3% | 0.00% | – |
| Q3 2019 | $19,000 | -5.0% | 2,344 | +7.4% | 0.00% | – |
| Q2 2019 | $20,000 | +300.0% | 2,183 | +247.1% | 0.00% | – |
| Q1 2019 | $5,000 | +25.0% | 629 | -28.0% | 0.00% | – |
| Q4 2018 | $4,000 | +300.0% | 874 | +616.4% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 122 | -3.2% | 0.00% | – |
| Q2 2018 | $1,000 | – | 126 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,545,573 | $3,447,000 | 1.85% |
| P.A.W. CAPITAL CORP | 200,000 | $446,000 | 0.67% |
| SANDERS MORRIS HARRIS LLC | 848,048 | $2,020,000 | 0.50% |
| Monaco Asset Management SAM | 458,851 | $1,023,000 | 0.39% |
| Bleichroeder LP | 555,000 | $1,238,000 | 0.26% |
| APOGEM CAPITAL LLC | 110,614 | $247,000 | 0.25% |
| Slate Path Capital LP | 1,483,619 | $3,308,000 | 0.22% |
| Voss Capital, LLC | 200,000 | $446,000 | 0.13% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $1,067,000 | 0.11% |
| CARLSON CAPITAL L P | 535,000 | $1,193,000 | 0.09% |